^
almost2years
A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions (clinicaltrials.gov)
P1, N=11, Completed, Apros Therapeutics, Inc | Recruiting --> Completed | N=36 --> 11 | Trial completion date: Dec 2023 --> Jan 2023 | Trial primary completion date: Oct 2023 --> Jan 2023
Trial completion • Enrollment change • Trial completion date • Trial primary completion date • Metastases
|
MSI (Microsatellite instability)
|
MSI-H/dMMR
|
APR003
almost4years
Clinical • Enrollment open
|
MSI (Microsatellite instability)
|
MSI-H/dMMR
|
APR003
almost4years
Clinical • New P1 trial
|
MSI (Microsatellite instability)
|
MSI-H/dMMR
|
APR003